학술논문
Coil Embolization of True, Common and Proper, Hepatic Artery Aneurysms: Technique, Safety and Outcome.
Document Type
Academic Journal
Author
Van Holsbeeck A; Department of Radiology, AZ Sint-Jan Hospital Brugge, Brugge, Belgium.; Department of Radiology, AZ Sint-Lucas Hospital Brugge, Brugge, Belgium.; Dhondt E; Department of Radiology, University Hospital Gent, Ghent, Belgium.; Marrannes J; Department of Radiology, AZ Sint-Jan Hospital Brugge, Brugge, Belgium.; Department of Radiology, AZ Sint-Lucas Hospital Brugge, Brugge, Belgium.; Claus E; Department of Radiology, University Hospital Leuven, Herestraat 49, 3000, Louven, Belgium.; Bonne L; Department of Radiology, University Hospital Leuven, Herestraat 49, 3000, Louven, Belgium.; Defreyne L; Department of Radiology, University Hospital Gent, Ghent, Belgium.; Maleux G; Department of Radiology, University Hospital Leuven, Herestraat 49, 3000, Louven, Belgium. geert.maleux@uzleuven.be.
Source
Publisher: Springer Verlag Country of Publication: United States NLM ID: 8003538 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-086X (Electronic) Linking ISSN: 01741551 NLM ISO Abbreviation: Cardiovasc Intervent Radiol Subsets: MEDLINE
Subject
Language
English
Abstract
Purpose: To retrospectively assess the safety and efficacy of coil embolization for catheter-directed true common and proper hepatic artery aneurysm exclusion.
Materials and Methods: Nine consecutive patients (2005-2021) in two university centers presenting with true common and proper hepatic artery aneurysms (> 2 cm in diameter) were treated with 'frontdoor-backdoor' coil embolization. Patients presenting with a hepatic artery pseudoaneurysm, mycotic aneurysm or patients with small (< 2 cm diameter) aneurysms and followed up by imaging were excluded. Technical and clinical success was defined as complete coil-exclusion of the aneurysm on completion angiography and absence of post-embolization adverse events, in particular mass effect or hemorrhage, respectively. Patient characteristics, technical and clinical success, liver function tests and follow-up results were assessed based on the patients' electronic medical records.
Results: Technical and 30-day clinical success was achieved in all procedures (100%). No major procedural complications were reported. Liver function test values were available in 6/9 patients, showing transient elevation of bilirubin in one patient. No end organ ischemia was reported. The mean clinical follow-up period of the study patients was 72 months (12-168 months). Long-term stable occlusion of the hepatic aneurysms was achieved in 9/9 patients (100%). One patient showed late complication (3 years) with coil migration into a bulbar ulcer, without aneurysm recanalization, however with fatal outcome.
Conclusion: Coil embolization for the endovascular exclusion of true common and proper hepatic artery aneurysms is safe and effective.
(© 2023. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).)
Materials and Methods: Nine consecutive patients (2005-2021) in two university centers presenting with true common and proper hepatic artery aneurysms (> 2 cm in diameter) were treated with 'frontdoor-backdoor' coil embolization. Patients presenting with a hepatic artery pseudoaneurysm, mycotic aneurysm or patients with small (< 2 cm diameter) aneurysms and followed up by imaging were excluded. Technical and clinical success was defined as complete coil-exclusion of the aneurysm on completion angiography and absence of post-embolization adverse events, in particular mass effect or hemorrhage, respectively. Patient characteristics, technical and clinical success, liver function tests and follow-up results were assessed based on the patients' electronic medical records.
Results: Technical and 30-day clinical success was achieved in all procedures (100%). No major procedural complications were reported. Liver function test values were available in 6/9 patients, showing transient elevation of bilirubin in one patient. No end organ ischemia was reported. The mean clinical follow-up period of the study patients was 72 months (12-168 months). Long-term stable occlusion of the hepatic aneurysms was achieved in 9/9 patients (100%). One patient showed late complication (3 years) with coil migration into a bulbar ulcer, without aneurysm recanalization, however with fatal outcome.
Conclusion: Coil embolization for the endovascular exclusion of true common and proper hepatic artery aneurysms is safe and effective.
(© 2023. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).)